CTOs on the Move

Outset Medical

www.outsetmedical.com

 
Outset is a pioneering medical technology company that always puts the patient before the machine. Our human-centered model is designed to dramatically improve not only the care experience – for patients, families, providers and physicians alike – but also cost-efficiencies for providers. And to achieve this goal, we brought together the most dedicated, creative minds from dialysis with the most dedicated, creative minds from other healthcare fields, in the belief that cross-fertilization – along with hard work – is the surest path to invention. Because we believe a dialysis machine should be as easy to use as an everyday consumer ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Funding

Outset Medical raised $91M on 06/10/2015
Outset Medical raised $132M on 08/28/2018
Outset Medical raised $125M on 02/05/2020
Outset Medical raised $149.7M on 04/13/2021

Similar Companies

Abbey Delray South Communities

Abbey Delray South is part of Lifespace Communities, Inc., a not-for-profit, multistate system of senior living communities that currently serves more than 5,100 people. For more than 40 years, Lifespace has created beautiful spaces for seniors to thrive and celebrate life every day. With decades of success and financial stability under its belt, Lifespace has earned national respect and recognition and, even more importantly, the trust of thousands of team members, residents and their families.

Transcend Health

Transcend Health is a healthcare company that provides a digital health platform for first responders, encompassing health, physical fitness, training, and wellness. They also offer a Direct Primary Care model for employers to provide superior access t...

Citicorp Vendor Finance

Citicorp Vendor Finance is a Mount Laurel, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Geonetric

Geonetric is a Cedar Rapids, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cardionomic

Unlike traditional approaches that only address symptoms, Cardionomic addresses the conditions root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality. This breakthrough therapy is also expected to increase pharmacological tolerance at discharge, which will reduce costly readmission and extend life. Spun off from Denali Medical II, a New Enterprise Associates (NEA) backed incubator, Cardionomic is funded by NEA, Greatbatch Medical and Cleveland Clinic Foundation.